D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 139 Citations 65,694 1,481 World Ranking 989 National Ranking 107

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Mutation

Genetics, Muscular dystrophy, Pathology, Congenital muscular dystrophy and Duchenne muscular dystrophy are his primary areas of study. In his research, RYR1, Nemaline myopathy and Genotype is intimately related to Congenital myopathy, which falls under the overarching field of Genetics. Francesco Muntoni interconnects Limb-girdle muscular dystrophy, Dystroglycan, LMNA and Skeletal muscle in the investigation of issues within Muscular dystrophy.

His Pathology research includes themes of Internal medicine, Gene mutation, Compound heterozygosity and Cardiomyopathy. His work deals with themes such as Physical therapy, Eteplirsen, Pediatrics and Bioinformatics, which intersect with Duchenne muscular dystrophy. His Dystrophin study incorporates themes from Molecular biology, Exon skipping and Exon.

His most cited work include:

  • Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy (1104 citations)
  • Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. (1045 citations)
  • Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy (719 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Duchenne muscular dystrophy, Pathology, Muscular dystrophy, Genetics and Internal medicine. His work is dedicated to discovering how Duchenne muscular dystrophy, Physical therapy are connected with Physical medicine and rehabilitation and other disciplines. In most of his Pathology studies, his work intersects topics such as Anatomy.

His study explores the link between Muscular dystrophy and topics such as Skeletal muscle that cross with problems in Cell biology. His biological study spans a wide range of topics, including Endocrinology and Cardiology. In his research on the topic of Dystrophin, Molecular biology and RNA splicing is strongly related with Exon.

He most often published in these fields:

  • Duchenne muscular dystrophy (22.81%)
  • Pathology (20.63%)
  • Muscular dystrophy (20.29%)

What were the highlights of his more recent work (between 2017-2021)?

  • Duchenne muscular dystrophy (22.81%)
  • Internal medicine (17.49%)
  • Spinal muscular atrophy (10.38%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Duchenne muscular dystrophy, Internal medicine, Spinal muscular atrophy, Muscular dystrophy and Pediatrics. His work in the fields of Duchenne muscular dystrophy, such as Dystrophin, intersects with other areas such as In patient. His Dystrophin research incorporates themes from Exon skipping, Cell biology and Exon.

Internal medicine is frequently linked to Endocrinology in his study. As a member of one scientific family, Francesco Muntoni mostly works in the field of Spinal muscular atrophy, focusing on Bioinformatics and, on occasion, Myostatin and Disease. Within one scientific family, Francesco Muntoni focuses on topics pertaining to Pathology under Muscular dystrophy, and may sometimes address concerns connected to Sarcolemma.

Between 2017 and 2021, his most popular works were:

  • Congenital myopathies: disorders of excitation–contraction coupling and muscle contraction (93 citations)
  • Congenital myopathies: disorders of excitation–contraction coupling and muscle contraction (93 citations)
  • Neurofilament as a potential biomarker for spinal muscular atrophy (48 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Mutation

His scientific interests lie mostly in Duchenne muscular dystrophy, Internal medicine, Dystrophin, Spinal muscular atrophy and Muscular dystrophy. The Duchenne muscular dystrophy study combines topics in areas such as Nonsense mutation, Ambulatory, Clinical trial and Disease progression. His Internal medicine course of study focuses on Endocrinology and Antisense therapy.

While the research belongs to areas of Dystrophin, Francesco Muntoni spends his time largely on the problem of Exon, intersecting his research to questions surrounding RNA splicing. His Spinal muscular atrophy research focuses on Gerontology and how it relates to MEDLINE. In his study, Congenital muscular dystrophy and Myopathy is strongly linked to Genetic heterogeneity, which falls under the umbrella field of Muscular dystrophy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy

Gisèle Bonne;M R Di Barletta;S Varnous;H M Bécane.
Nature Genetics (1999)

1538 Citations

Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.

Diane Fatkin;Calum MacRae;Takeshi Sasaki;Matthew R. Wolff.
The New England Journal of Medicine (1999)

1438 Citations

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

Richard S. Finkel;Eugenio Mercuri;Basil T. Darras;Anne M. Connolly.
The New England Journal of Medicine (2017)

1352 Citations

Dystrophin and mutations: one gene, several proteins, multiple phenotypes

Francesco Muntoni;Silvia Torelli;Alessandra Ferlini.
Lancet Neurology (2003)

1181 Citations

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.

Sebahattin Cirak;Virginia Arechavala-Gomeza;Michela Guglieri;Lucy Feng.
The Lancet (2011)

1157 Citations

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

Maria Kinali;Maria Kinali;Virginia Arechavala-Gomeza;Lucy Feng;Sebahattin Cirak.
Lancet Neurology (2009)

924 Citations

Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area.

Gian Luigi Gessa;Francesco Muntoni;Maria Collu;Lidia Vargiu.
Brain Research (1985)

919 Citations

Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.

Martin Brockington;Derek J. Blake;Paola Prandini;Susan C. Brown.
American Journal of Human Genetics (2001)

644 Citations

Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C

Martin Brockington;Yeliz Yuva;Paola Prandini;Susan C. Brown.
Human Molecular Genetics (2001)

561 Citations

BRIEF REPORT - DELETION OF THE DYSTROPHIN MUSCLE-PROMOTER REGION ASSOCIATED WITH X-LINKED DILATED CARDIOMYOPATHY

Francesco Muntoni;Milena Cau;Antonello Ganau;Rita Congiu.
The New England Journal of Medicine (1993)

551 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Francesco Muntoni

Hanns Lochmüller

Hanns Lochmüller

University of Freiburg

Publications: 153

Enrico Bertini

Enrico Bertini

Boston Children's Hospital

Publications: 143

Eugenio Mercuri

Eugenio Mercuri

Catholic University of the Sacred Heart

Publications: 140

Nigel G. Laing

Nigel G. Laing

University of Western Australia

Publications: 140

Volker Straub

Volker Straub

Newcastle University

Publications: 137

Ichizo Nishino

Ichizo Nishino

Tokyo Medical University

Publications: 130

Annemieke Aartsma-Rus

Annemieke Aartsma-Rus

Leiden University Medical Center

Publications: 123

Jerry R. Mendell

Jerry R. Mendell

The Ohio State University

Publications: 101

Eric P. Hoffman

Eric P. Hoffman

Binghamton University

Publications: 100

Heinz Jungbluth

Heinz Jungbluth

King's College London

Publications: 99

Kathryn N. North

Kathryn N. North

University of Melbourne

Publications: 96

Kate Bushby

Kate Bushby

Newcastle University

Publications: 94

Kevin P. Campbell

Kevin P. Campbell

University of Iowa

Publications: 94

Giacomo P. Comi

Giacomo P. Comi

University of Milan

Publications: 85

Shin'ichi Takeda

Shin'ichi Takeda

National Center of Neurology and Psychiatry

Publications: 84

Alan H. Beggs

Alan H. Beggs

Harvard Medical School

Publications: 83

Trending Scientists

Dimitrios Tzovaras

Dimitrios Tzovaras

Centre for Research and Technology Hellas

Rosie Jones

Rosie Jones

Spotify

Knut Reinert

Knut Reinert

Freie Universität Berlin

F. J. Himpsel

F. J. Himpsel

University of Wisconsin–Madison

Albert Tenesa

Albert Tenesa

University of Edinburgh

Donald W. Tinkle

Donald W. Tinkle

University of Michigan–Ann Arbor

Felicita Scapini

Felicita Scapini

University of Florence

Antonia Follenzi

Antonia Follenzi

University of Eastern Piedmont Amadeo Avogadro

Michael P. Harms

Michael P. Harms

Washington University in St. Louis

Gerard B. Nash

Gerard B. Nash

University of Birmingham

Jörg M. Fegert

Jörg M. Fegert

University of Ulm

Jari-Erik Nurmi

Jari-Erik Nurmi

University of Jyväskylä

Ronald K. Hambleton

Ronald K. Hambleton

University of Massachusetts Amherst

Philip J. Cowen

Philip J. Cowen

University of Oxford

Dihua Yu

Dihua Yu

The University of Texas MD Anderson Cancer Center

Richard E. Adams

Richard E. Adams

Kent State University

Something went wrong. Please try again later.